Clustering data with hclust algorithm for (Study ST000674)

(Analysis AN001034)
MetaboliteStructureF1F2
PC 38:7; [M-Ac-H]-@5.70ME1860650.721.28
lysoPE 18:1; [M-H]-@1.81ME1861960.721.28
PC 38:5; [M-Ac-H]-@6.49ME1860620.721.28
PS 40:7; [M-H]-@5.32ME1861890.731.27
lysoPE 20:4; [M-H]-@1.29ME1862030.731.27
PC 34:0; [M-Ac-H]-@6.79ME1860360.731.27
PG 38:7; [M-H]-@4.36ME1861630.741.26
PC 41:6; [M-Ac-H]-@7.26ME1860750.741.26
PE 36:6; [M-H]-@5.56ME1861080.741.26
CL 82:1; [M-2H](2-)@8.46ME1860020.761.24
FFA(22:0)ME1860110.751.25
PE 34:3; [M-H]-@5.98ME1860930.751.25
PC 42:4; [M-Ac-H]-@8.18ME1860780.711.29
PE 40:4; [M-H]-@7.64ME1861320.701.30
FFA(24:0)ME1860150.701.30
PE 40:4; [M-H]-@7.35ME1861310.701.30
PC 36:5; [M-Ac-H]-@5.87ME1860500.671.33
PC 44:4; [M-Ac-H]-@9.03ME1860840.671.33
PE 42:7; [M-H]-@7.00ME1861420.681.32
PC 38:1; [M-Ac-H]-@8.24ME1860570.681.32
PE 40:3; [M-H]-@7.86ME1861300.681.32
PG 34:3; [M-H]-@4.70ME1861480.691.31
PG 36:4; [M-H]-@5.40ME1861540.691.31
lysoPE 17:1; [M-H]-@1.50ME1861940.591.41
lysoPE 20:1; [M-H]-@2.67ME1862000.571.43
PE 39:4; [M-H]-@7.23ME1861250.571.43
PC 36:6; [M-Ac-H]-@5.54ME1860510.651.35
CerP 34:1; [M-H]-@6.03ME1860030.651.35
PC 32:1; [M-Ac-H]-@6.25ME1860320.651.35
PC 34:3; [M-Ac-H]-@5.94ME1860400.641.36
PC 40:3; [M-Ac-H]-@7.91ME1860700.641.36
FFA(22:1)ME1860120.631.37
PE 38:7; [M-H]-@5.75ME1861230.631.37
PC 32:2; [M-Ac-H]-@5.78ME1860330.621.38
PE 34:4; [M-H]-@5.56ME1860940.621.38
PE 32:1; [M-H]-@6.26ME1860870.601.40
PE 32:2; [M-H]-@5.78ME1860880.611.39
CL 66:3; [M-2H](2-)@5.99ME1859890.611.39
PC 40:2; [M-Ac-H]-@8.29ME1860690.611.39
PC 44:12; [M-Ac-H]-@5.69ME1860830.501.50
PE 36:5; [M-H]-@5.88ME1861070.521.48
PC 42:6; [M-Ac-H]-@7.59ME1860800.341.66
lysoPE 20:0; [M-H]-@3.47ME1861990.461.54
lysoPE 20:5; [M-H]-@1.02ME1862040.441.56
PG 32:1; [M-H]-@5.23ME1861450.421.58
lysoPE 16:1; [M-H]-@1.22ME1861920.391.61
PG 42:11; [M-H]-@4.13ME1861700.401.60
CL 72:7; [M-2H](2-)@9.06ME1859941.090.91
PG 44:12; [M-H]-@4.41ME1861761.090.91
plasmenyl-PE 40:5; [M-H]-@6.99ME1862261.080.92
PC 35:1; [M-Ac-H]-@7.29ME1860421.080.92
PC 36:3; [M-Ac-H]-@6.56ME1860481.080.92
plasmenyl-PE 42:5; [M-H]-@7.91ME1862301.130.87
plasmenyl-PE 38:3; [M-H]-@7.61ME1862191.120.88
PC 38:4; [M-Ac-H]-@6.76ME1860601.120.88
PC 38:4; [M-Ac-H]-@7.04ME1860611.120.88
plasmenyl-PE 34:0; [M-H]-@7.28ME1862081.110.89
PG 40:8; [M-H]-@4.54ME1861671.110.89
PE 42:8; [M-H]-@6.57ME1861431.110.89
PE 35:4; [M-H]-@6.08ME1860991.110.89
PC 35:3; [M-Ac-H]-@6.23ME1860441.110.89
CL 72:5; [M-2H](2-)@9.47ME1859921.110.89
FFA(20:2)ME1860101.110.89
plasmenyl-PE 40:6; [M-H]-@7.20ME1862281.100.90
plasmenyl-PE 40:4; [M-H]-@7.79ME1862251.100.90
PE 40:6; [M-H]-@6.86ME1861351.100.90
PA 42:7; [M-H]-@5.78ME1860291.100.90
PE 38:1; [M-H]-@7.98ME1861141.100.90
plasmenyl-PE 34:1; [M-H]-@7.26ME1862091.060.94
PE 38:5; [M-H]-@6.55ME1861211.060.94
PE 36:3; [M-H]-@5.93ME1861041.060.94
PC 42:9; [M-Ac-H]-@6.12ME1860821.060.94
PC 37:6; [M-Ac-H]-@5.91ME1860561.060.94
lysoPE 22:4; [M-H]-@1.79ME1862051.060.94
CL 72:6; [M-2H](2-)@9.29ME1859931.060.94
lysoPE 17:0; [M-H]-@2.08ME1861931.060.94
PI 34:2; [M-H]-@5.23ME1861771.070.93
PC 37:2; [M-Ac-H]-@7.43ME1860531.070.93
PE 36:2; [M-H]-@7.01ME1861031.070.93
PS 38:6; [M-H]-@5.23ME1861871.040.96
PC 40:8; [M-Ac-H]-@5.92ME1860741.040.96
PC 36:4; [M-Ac-H]-@6.22ME1860491.040.96
lysoPE 19:0; [M-H]-@2.87ME1861981.040.96
PA 40:4; [M-H]-@6.13ME1860251.040.96
PI 36:3; [M-H]-@5.39ME1861791.050.95
PC 37:1; [M-Ac-H]-@7.85ME1860521.050.95
PG 38:2; [M-H]-@6.15ME1861561.050.95
plasmenyl-PE 42:6; [M-H]-@7.77ME1862311.030.97
plasmenyl-PE 38:4; [M-H]-@7.30ME1862211.030.97
FFA(22:2)ME1860131.030.97
PI 38:4; [M-H]-@5.81ME1861821.030.97
PS 38:4; [M-H]-@5.97ME1861861.020.98
PG 38:4; [M-H]-@5.40ME1861581.020.98
PE 37:5; [M-H]-@6.22ME1861121.020.98
PE 36:1; [M-H]-@7.49ME1861021.020.98
FFA(24:1)ME1860161.020.98
PE 35:3; [M-H]-@6.26ME1860981.020.98
plasmenyl-PE 38:6; [M-H]-@6.60ME1862231.010.99
PI 36:2; [M-H]-@5.89ME1861781.010.99
PG 38:5; [M-H]-@5.06ME1861611.010.99
PE 40:2; [M-H]-@8.04ME1861291.010.99
PC 32:0; [M-Ac-H]-@6.78ME1860311.010.99
PC 34:0; [M-Ac-H]-@7.50ME1860371.010.99
PE 38:3; [M-H]-@7.28ME1861181.001.00
PC 39:7; [M-Ac-H]-@6.06ME1860681.001.00
PC 35:4; [M-Ac-H]-@6.09ME1860451.001.00
CL 68:1; [M-2H](2-)@7.23ME1859901.001.00
IS PC 34:0;[M-Ac-H]-ME1860191.001.00
PC 42:2; [M-Ac-H]-@9.07ME1860770.991.01
FFA(18:0)ME1860050.991.01
PC 30:1; [M-Ac-H]-@5.60ME1860300.991.01
plasmenyl-PE 34:2; [M-H]-@6.77ME1862100.781.22
PC 34:1; [M-Ac-H]-@6.84ME1860380.781.22
PE 38:3; [M-H]-@6.61ME1861170.781.22
PE 32:0; [M-H]-@6.80ME1860860.771.23
PG 36:5; [M-H]-@4.49ME1861550.771.23
PE 39:3; [M-H]-@7.57ME1861240.791.21
PG 40:9; [M-H]-@4.20ME1861680.801.20
PS 36:4; [M-H]-@5.29ME1861850.801.20
PE 36:4; [M-H]-@6.23ME1861060.861.14
PE 41:6; [M-H]-@7.16ME1861390.861.14
PG 38:5; [M-H]-@5.51ME1861600.851.15
PC 38:6; [M-Ac-H]-@11.23ME1860630.851.15
Arachidonic acidME1859880.851.15
lysoPE 18:2; [M-H]-@1.34ME1861970.851.15
PE 39:7; [M-H]-@6.08ME1861270.841.16
PC 36:1; [M-Ac-H]-@7.58ME1860460.841.16
PC 42:5; [M-Ac-H]-@7.75ME1860790.841.16
PC 38:2; [M-Ac-H]-@7.74ME1860580.831.17
PE 40:9; [M-H]-@5.54ME1861380.831.17
PG 34:2; [M-H]-@5.20ME1861470.821.18
lysoPE 16:0; [M-H]-@1.69ME1861910.821.18
lysoPE 20:2; [M-H]-@2.09ME1862010.821.18
PE 38:4; [M-H]-@7.03ME1861190.811.19
PE 33:1; [M-H]-@6.62ME1860890.811.19
PE 38:4; [M-H]-@6.71ME1861200.811.19
PE 42:4; [M-H]-@8.14ME1861410.871.13
CL 76:10; [M-2H](2-)@9.06ME1859980.871.13
PC 33:1; [M-Ac-H]-@6.59ME1860340.871.13
PI 36:4; [M-H]-@5.19ME1861800.881.12
PC 40:4; [M-Ac-H]-@7.59ME1860710.881.12
FFA(20:0)ME1860080.881.12
lysoPE 22:6; [M-H]-@1.24ME1862070.881.12
PG 42:7; [M-H]-@5.47ME1861710.901.10
lysoPE 18:0; [M-H]-@2.47ME1861950.901.10
PE 40:1; [M-H]-@8.48ME1861280.901.10
plasmenyl-PE 40:5; [M-H]-@7.61ME1862270.891.11
PG 42:10; [M-H]-@4.51ME1861690.891.11
PG 38:6; [M-H]-@4.70ME1861620.891.11
PE 40:5; [M-H]-@6.29ME1861330.891.11
PE 37:4; [M-H]-@6.70ME1861110.891.11
lysoPE 20:3; [M-H]-@1.60ME1862020.891.11
PC 39:6; [M-Ac-H]-@6.51ME1860670.891.11
PG 34:1; [M-H]-@5.80ME1861460.951.05
PE 38:6; [M-H]-@6.15ME1861220.951.05
PE 35:2; [M-H]-@6.75ME1860970.951.05
CL 74:9; [M-2H](2-)@8.99ME1859970.951.05
PC 39:4; [M-Ac-H]-@7.38ME1860660.951.05
PE 34:1; [M-H]-@6.86ME1860910.961.04
PC 42:10; [M-Ac-H]-@5.82ME1860760.961.04
PC 40:6; [M-Ac-H]-@6.84ME1860720.961.04
FFA(16:0)ME1860040.961.04
FFA(18:1)ME1860060.961.04
PA 40:7; [M-H]-@5.15ME1860280.981.02
plasmenyl-PE 34:3; [M-H]-@6.40ME1862110.971.03
PI 38:5; [M-H]-@5.32ME1861830.971.03
PE 40:8; [M-H]-@5.98ME1861370.971.03
PE 37:2; [M-H]-@7.24ME1861100.971.03
FFA(18:2)ME1860070.971.03
PE 36:3; [M-H]-@6.56ME1861050.971.03
PG 36:4; [M-H]-@4.95ME1861530.941.06
PE 36:0; [M-H]-@7.95ME1861000.941.06
PE 34:2; [M-H]-@6.41ME1860920.941.06
PC 42:7; [M-Ac-H]-@6.94ME1860810.941.06
PC 38:6; [M-Ac-H]-@6.14ME1860640.941.06
CL 76:11; [M-2H](2-)@9.01ME1859990.941.06
PC 36:2; [M-Ac-H]-@7.00ME1860470.941.06
PE 40:7; [M-H]-@6.39ME1861360.931.07
FFA(20:1)ME1860090.931.07
lysoPE 22:5; [M-H]-@1.58ME1862060.931.07
plasmenyl-PE 36:4; [M-H]-@6.69ME1862160.911.09
PE 42:1; [M-H]-@9.03ME1861400.911.09
CL 70:4; [M-2H](2-)@9.40ME1859910.911.09
PC 38:3; [M-Ac-H]-@7.30ME1860590.911.09
plasmenyl-PE 38:5; [M-H]-@6.77ME1862220.921.08
PE 38:2; [M-H]-@7.57ME1861150.921.08
PC 34:2; [M-Ac-H]-@6.35ME1860390.921.08
PC 40:7; [M-Ac-H]-@6.28ME1860730.921.08
plasmenyl-PE 38:4; [M-H]-@5.89ME1862201.220.78
plasmenyl-PE 36:3; [M-H]-@7.00ME1862151.220.78
CL 80:15; [M-2H](2-)@9.10ME1860011.220.78
PG 40:5; [M-H]-@5.59ME1861641.220.78
PC 37:4; [M-Ac-H]-@6.67ME1860551.200.80
PS 42:10; [M-H]-@4.77ME1861901.200.80
plasmenyl-PE 38:2; [M-H]-@8.00ME1862181.150.85
PE 38:2; [M-H]-@7.02ME1861161.150.85
PG 40:7; [M-H]-@4.96ME1861661.150.85
PS 40:6; [M-H]-@5.91ME1861881.180.82
PS 36:2; [M-H]-@5.83ME1861841.180.82
PE 37:1; [M-H]-@7.70ME1861091.180.82
PE 36:1; [M-H]-@6.96ME1861011.180.82
PC 34:4; [M-Ac-H]-@5.67ME1860411.180.82
PA 40:6; [M-H]-@5.64ME1860271.180.82
FFA(24:2)ME1860171.180.82
PA 34:1; [M-H]-@5.66ME1860201.180.82
PG 40:6; [M-H]-@5.37ME1861651.190.81
PE 33:2; [M-H]-@6.07ME1860901.190.81
PE 35:0; [M-H]-@7.64ME1860951.190.81
plasmenyl-PE 40:3; [M-H]-@8.01ME1862241.170.83
PI 38:3; [M-H]-@6.10ME1861811.170.83
CL 74:8; [M-2H](2-)@9.13ME1859961.170.83
PG 36:3; [M-H]-@5.35ME1861521.170.83
PC 35:2; [M-Ac-H]-@6.76ME1860431.160.84
PE 40:5; [M-H]-@7.23ME1861341.160.84
PG 36:2; [M-H]-@5.85ME1861501.330.67
PG 36:2; [M-H]-@6.06ME1861511.330.67
PA 38:2; [M-H]-@6.38ME1860221.300.70
PA 38:4; [M-H]-@5.50ME1860231.300.70
plasmenyl-PE 38:1; [M-H]-@8.19ME1862171.310.69
PE 37:6; [M-H]-@6.01ME1861131.310.69
PG 38:3; [M-H]-@5.74ME1861571.310.69
PG 42:8; [M-H]-@5.16ME1861721.320.68
plasmenyl-PE 42:4; [M-H]-@8.23ME1862291.320.68
PC 37:3; [M-Ac-H]-@6.85ME1860541.240.76
PG 42:9; [M-H]-@4.81ME1861731.240.76
PE 35:1; [M-H]-@7.22ME1860961.250.75
PG 38:4; [M-H]-@6.04ME1861591.250.75
plasmenyl-PE 36:2; [M-H]-@5.93ME1862131.280.72
PA 38:5; [M-H]-@5.28ME1860241.280.72
PG 32:0; [M-H]-@5.74ME1861441.280.72
plasmenyl-PE 36:2; [M-H]-@7.36ME1862141.260.74
FFA(22:3)ME1860141.260.74
CL 72:8; [M-2H](2-)@8.87ME1859951.260.74
CL 80:10; [M-2H](2-)@6.40ME1860001.260.74
plasmenyl-PE 36:1; [M-H]-@7.80ME1862121.270.73
PA 36:3; [M-H]-@5.32ME1860211.270.73
PC 33:2; [M-Ac-H]-@6.16ME1860351.270.73
FFA(24:3)ME1860181.560.44
PA 40:5; [M-H]-@6.04ME1860261.400.60
PE 39:6; [M-H]-@6.57ME1861261.370.63
PG 36:1; [M-H]-@6.46ME1861491.380.62
PG 44:11; [M-H]-@4.78ME1861751.490.51
PE 30:0; [M-H]-@6.16ME1860851.460.54
PG 44:10; [M-H]-@5.09ME1861741.460.54

Factors:

F1Type:Bmal1 knockdown
F2Type:control
Data matrix
  logo